Indian court rejects AstraZeneca’s injunction request
24-11-2020
Daiichi and AstraZeneca fight back in cancer drug dispute with Seagen
18-11-2020
Roland Magnusson / Shutterstock.com
AstraZeneca has announced it will acquire Boston-based biopharmaceutical company Alexion Pharmaceuticals, in what is potentially the biggest life sciences deal of this year.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
AstraZeneca, Alexion, biopharma, mergers and acquisitions, M&A, immunology,
